Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Share cancellation

Livzon Pharmaceutical Group announced on Friday that as of Jun. 27, 2024, it has repurchased a cumulative total of 2.78 million H shares, and all of which have been cancelled.

FAST NEWS: Livzon Pharma cancels repurchased H shares

The Latest: Livzon Pharmaceutical Group Inc. (1513.HK) announced on Friday that as of Jun. 27, 2024, it has repurchased a cumulative total of 2.78 million H shares, and all of which…
July 2, 2024
1513.HK

Recent Articles

Livzon Pharmaceutical Group announced on Friday that as of Jun. 27, 2024, it has repurchased a cumulative total of 2.78 million H shares, and all of which have been cancelled.
July 2, 2024

FAST NEWS: Livzon Pharma cancels repurchased H shares

1513.HK

RELATED ARTICLES

  1. Eshallgo enters cloud console gaming
    December 27, 2024
    Eshallgo looks skyward to cloud gaming to offset sputtering office business
    EHGO.US
  2. December 24, 2024
    BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
    2196.HK 600196.SHG
  3. March 26, 2025
    Qifu shares rally as credit tech takes off
    3660.HK QFIN.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.